Construction and analysis of miRNA-mRNA regulatory networks in the radioresistance of nasopharyngeal carcinoma

Chai L et al (2018) MiR-497-5p, miR-195-5p and miR-455-3p function as tumor suppressors by targeting hTERT in melanoma A375 cells. Cancer Manag Res 10:989–1003. https://doi.org/10.2147/CMAR.S163335

Chang JT, Nevins JR (2006) GATHER: a systems approach to interpreting genomic signatures. Bioinformatics 22:2926–2933. https://doi.org/10.1093/bioinformatics/btl483

Chen L et al (2018) miR-203a-3p promotes colorectal cancer proliferation and migration by targeting PDE4D. Am J Cancer Res 8:2387–2401

Chu C, Niu X, Ou X, Hu C (2019) LAPTM4B knockdown increases the radiosensitivity of EGFR-overexpressing radioresistant nasopharyngeal cancer cells by inhibiting autophagy. Onco Targets Ther 12:5661–5677. https://doi.org/10.2147/OTT.S207810

Dragomir M, Mafra ACP, Dias SMG, Vasilescu C, Calin GA (2018) Using microRNA networks to understand cancer. Int J Mol Sci. https://doi.org/10.3390/ijms19071871

Du B, Zhang P, Tan Z, Xu J (2017) MiR-1202 suppresses hepatocellular carcinoma cells migration and invasion by targeting cyclin dependent kinase 14. Biomed Pharmacother 96:1246–1252. https://doi.org/10.1016/j.biopha.2017.11.090

Fu Z, Zuo C, Sheehan CE, Patil DT, Lin J, Yang Z, Lee H (2019) Novel finding of paired box 5 (PAX5) cytoplasmic staining in well-differentiated rectal neuroendocrine tumors (Carcinoids) and its diagnostic and potentially prognostic utility. Appl Immunohistochem Mol Morphol 27:454–460. https://doi.org/10.1097/PAI.0000000000000635

Gao X et al (2018) miR-455-3p serves as prognostic factor and regulates the proliferation and migration of non-small cell lung cancer through targeting HOXB5. Biochem Biophys Res Commun 495:1074–1080. https://doi.org/10.1016/j.bbrc.2017.11.123

Ge P, Cao L, Chen X, Jing R, Yue W (2019) miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer. BMC cancer 19:1203. https://doi.org/10.1186/s12885-019-6416-4

Gioacchini FM, Tulli M, Kaleci S, Magliulo G, Re M (2017) Prognostic aspects in the treatment of juvenile nasopharyngeal carcinoma: a systematic review. Eur Arch Otorhinolaryngol 274:1205–1214. https://doi.org/10.1007/s00405-016-4154-7

Guo Y, Zhang Y, Zhang SJ, Ma YN, He Y (2019) Comprehensive analysis of key genes and microRNAs in radioresistant nasopharyngeal carcinoma. BMC Med Genomics 12:73. https://doi.org/10.1186/s12920-019-0507-6

Hou R, Yang Z, Wang S, Chu D, Liu Q, Liu J, Jiang L (2017) miR-762 can negatively regulate menin in ovarian cancer. OncoTargets Ther 10:2127–2137. https://doi.org/10.2147/OTT.S127872

Huo W, Du M, Pan X, Zhu X, Gao Y, Li Z (2017) miR-203a-3p.1 targets IL-24 to modulate hepatocellular carcinoma cell growth and metastasis. FEBS Open Bio 7:1085–1091. https://doi.org/10.1002/2211-5463.12248

Jiang N et al (2017) MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma. J Exp Clin Cancer Res 36:138. https://doi.org/10.1186/s13046-017-0604-3

Jiang X, Dai B, Feng L (2019a) miR-543 promoted the cell proliferation and invasion of nasopharyngeal carcinoma by targeting the JAM-A. Hum Cell 32:477–486. https://doi.org/10.1007/s13577-019-00274-0

Jiang Y, Jin S, Tan S, Shen Q, Xue Y (2019b) MiR-203 acts as a radiosensitizer of gastric cancer cells by directly targeting ZEB1. Onco Targets Ther 12:6093–6104. https://doi.org/10.2147/OTT.S197539

Lekka E, Hall J (2018) Noncoding RNAs in disease. FEBS Lett. https://doi.org/10.1002/1873-3468.13182

Li XH et al (2014) Integrated analysis of differential miRNA and mRNA expression profiles in human radioresistant and radiosensitive nasopharyngeal carcinoma cells. PLoS ONE 9:e87767. https://doi.org/10.1371/journal.pone.0087767

Li Y, Huang R, Wang L, Hao J, Zhang Q, Ling R, Yun J (2015) microRNA-762 promotes breast cancer cell proliferation and invasion by targeting IRF7 expression. Cell Prolif 48:643–649. https://doi.org/10.1111/cpr.12223

Luo M et al (2019) FOXO3a knockdown promotes radioresistance in nasopharyngeal carcinoma by inducing epithelial-mesenchymal transition and the Wnt/beta-catenin signaling pathway. Cancer Lett 455:26–35. https://doi.org/10.1016/j.canlet.2019.04.019

Molina-Cerrillo J, Alonso-Gordoa T, Gajate P, Grande E (2017) Bruton’s tyrosine kinase (BTK) as a promising target in solid tumors. Cancer Treat Rev 58:41–50. https://doi.org/10.1016/j.ctrv.2017.06.001

Nie X et al (2019) SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway. Cancer Med 8:1779–1792. https://doi.org/10.1002/cam4.2056

Perri F et al (2019) Management of recurrent nasopharyngeal carcinoma: current perspectives. OncoTargetsTher 12:1583–1591. https://doi.org/10.2147/ott.S188148

Quan Y, Song Q, Wang J, Zhao L, Lv J, Gong S (2017) MiR-1202 functions as a tumor suppressor in glioma cells by targeting Rab1A. Tumour Biol 39:1010428317697565. https://doi.org/10.1177/1010428317697565

Szklarczyk D et al (2019) STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47:D607–D613. https://doi.org/10.1093/nar/gky1131

Takashima Y et al (2020) miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma. PLoS ONE 15:e0229577. https://doi.org/10.1371/journal.pone.0229577

Tokar T et al (2018) mirDIP 4.1-integrative database of human microRNA target predictions. Nucleic Acids Res 46:D360–D370. https://doi.org/10.1093/nar/gkx1144

Wang T, Dong XM, Zhang FL, Zhang JR (2017) miR-206 enhances nasopharyngeal carcinoma radiosensitivity by targeting IGF1. Kaohsiung J Med Sci 33:427–432. https://doi.org/10.1016/j.kjms.2017.05.015

Wang G, Dong J, Deng L (2018) Overview of cantharidin and its analogues. Curr Med Chem 25:2034–2044. https://doi.org/10.2174/0929867324666170414165253

Wu S, Xie DL, Dai XY (2019) Down-regulation of miR-155 promotes apoptosis of nasopharyngeal carcinoma CNE-1 cells by targeting PI3K/AKT-FOXO3a signaling. Eur Rev Med Pharmacol Sci 23:7391–7398. https://doi.org/10.26355/eurrev_201909_18847

Yang S et al (2012) Identification of prognostic biomarkers for response to radiotherapy by DNA microarray in nasopharyngeal carcinoma patients. Int J Oncol 40:1590–1600. https://doi.org/10.3892/ijo.2012.1341

Yang X, Yan Z, Yang H, Ni H, Zhang L, Wang Y (2019) Clinical value of combined detection of miR-1202 and miR-195 in early diagnosis of cervical cancer. Oncology Lett 17:3387–3391. https://doi.org/10.3892/ol.2019.9956

Zhang N, Li Z, Bai F, Zhang S (2019) PAX5-induced upregulation of IDH1-AS1 promotes tumor growth in prostate cancer by regulating ATG5-mediated autophagy. Cell Death Dis 10:734. https://doi.org/10.1038/s41419-019-1932-3

Zhao Y et al (2017) High expression of Ki-67 acts a poor prognosis indicator in locally advanced nasopharyngeal carcinoma. Biochem Biophys Res Commun 494:390–396. https://doi.org/10.1016/j.bbrc.2017.09.118

Zhuo X, Chang A, Huang C, Yang L, Zhao H, Wu Y, Zhou Q (2015) Nanoparticle-mediated down-regulation of TWIST increases radiosensitivity of nasopharyngeal carcinoma cells via ERK pathway. Am J Cancer Res 5:1571–1579

Zucha MA, Wu AT, Lee WH, Wang LS, Lin WW, Yuan CC, Yeh CT (2015) Bruton’s tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer. Oncotarget 6:13255–13268. https://doi.org/10.18632/oncotarget.3658